Clinical Trial Update: Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing efavirenz-based versus nevirapine-based antiretroviral therapy in HIV-infected patients receiving rifampin. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• EFAVIRENZ (efavirenz)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Bamrasnaradura Infectious Diseases Institute | Conditions: HIV Infections, Tuberculosis | Phase 3 | Status: COMPLETED